Modern Biopharmaceuticals, 4 Volume Set PDF Download

Author: Jörg Knäblein
Publisher: John Wiley & Sons
ISBN: 352731184X
Category : Science
Languages : en
Pages : 2074

View

Book Description
The biopharmaceutical market has come along way since 1982 when the first biopharmaceutical product, recombinant human insulin, was launched. Over 120 such products are currently being marketed around the world including nine blockbuster drugs. The global market for biopharmaceuticals, which is currently valued at US$41 billion, has been growing at an impressive compound annual growth rate of 21% over the previous five years. With over one third of all pipe-line products in active development are biopharmaceuticals, this segment is set to continue outperforming the total pharmaceutical market and could easily reach US$100 billion by the end of this decade.

Author: Ganapathy Subramanian
Publisher: John Wiley & Sons
ISBN: 3527330291
Category : Medical
Languages : en
Pages : 945

View

Book Description
Systematically addressing the key steps and challenges along the biopharmaceutical production process, this two volume handbook provides key knowledge for medium to large scale producers of biopharmaceuticals. The volumes are divided into six major parts, on upstream technologies, protein recovery, process development, analytical technologies, quality control, and an outlook section that addresses new and emerging technologies, such as single-use processes and integrated process design. With contributions by some 40 experts from academia, as well as small and large biopharmaceutical companies, this unique handbook is full of valuable first-hand knowledge on how to produce biopharmaceuticals in a cost-effective and quality-controlled manner.

Author: Jörg Knäblein
Publisher: John Wiley & Sons
ISBN: 352731184X
Category : Science
Languages : en
Pages : 2074

View

Book Description
The biopharmaceutical market has come along way since 1982 when the first biopharmaceutical product, recombinant human insulin, was launched. Over 120 such products are currently being marketed around the world including nine blockbuster drugs. The global market for biopharmaceuticals, which is currently valued at US$41 billion, has been growing at an impressive compound annual growth rate of 21% over the previous five years. With over one third of all pipe-line products in active development are biopharmaceuticals, this segment is set to continue outperforming the total pharmaceutical market and could easily reach US$100 billion by the end of this decade.

Author: Jörg Knäblein
Publisher: John Wiley & Sons
ISBN: 3527669434
Category : Science
Languages : en
Pages : 724

View

Book Description
This collection of high-profile contributions provides a unique insight into the development of novel, successful biopharmaceuticals. Outstanding authors, including Nobel laureate Robert Huber as well as prominent company researchers and CEOs, present valuable insider knowledge, limiting their scope to those procedures and developments with proven potential for the biotechnology industry. They cover all relevant aspects, from the establishment of biotechnology parks, the development of successful compounds and the implementation of efficient manufacturing processes, right up to the establishment of advanced delivery routes.

Author: Rodney J. Y. Ho
Publisher: John Wiley & Sons
ISBN: 0471450278
Category : Science
Languages : en
Pages : 576

View

Book Description
Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs defines biotechnology from the perspective of pharmaceuticals. The first section focuses on the process of transforming a biologic macromolecule into a therapeutic agent, while the second section provides a brief overview of each class of macromolecule with respect to physiological role and clinical application. Additional detail is also provided in the second section for each FDA approved, recombinantly derived biopharmaceutical for each category of macromolecule. The final section looks to the future and the new advances that will enhance our ability to develop new macromolecules into effective biopharmaceuticals. This last section discusses various drug delivery strategies while also describing gene and cell therapy strategies.

Author: Alexander T. Florence
Publisher: CRC Press
ISBN: 1420065718
Category : Medical
Languages : en
Pages : 1220

View

Book Description
This new edition brings you up-to-date on the role of pharmaceutics and its future paradigms in the design of medicines. Contributions from over 30 international thought leaders cover the core disciplines of pharmaceutics and the impact of biotechnology, gene therapy, and cell therapy on current findings. Modern Pharmaceutics helps you stay current

Author: Shein-Chung Chow
Publisher: CRC Press
ISBN: 1351110268
Category : Medical
Languages : en
Pages : 2434

View

Book Description
Since the publication of the first edition in 2000, there has been an explosive growth of literature in biopharmaceutical research and development of new medicines. This encyclopedia (1) provides a comprehensive and unified presentation of designs and analyses used at different stages of the drug development process, (2) gives a well-balanced summary of current regulatory requirements, and (3) describes recently developed statistical methods in the pharmaceutical sciences. Features of the Fourth Edition: 1. 78 new and revised entries have been added for a total of 308 chapters and a fourth volume has been added to encompass the increased number of chapters. 2. Revised and updated entries reflect changes and recent developments in regulatory requirements for the drug review/approval process and statistical designs and methodologies. 3. Additional topics include multiple-stage adaptive trial design in clinical research, translational medicine, design and analysis of biosimilar drug development, big data analytics, and real world evidence for clinical research and development. 4. A table of contents organized by stages of biopharmaceutical development provides easy access to relevant topics. About the Editor: Shein-Chung Chow, Ph.D. is currently an Associate Director, Office of Biostatistics, U.S. Food and Drug Administration (FDA). Dr. Chow is an Adjunct Professor at Duke University School of Medicine, as well as Adjunct Professor at Duke-NUS, Singapore and North Carolina State University. Dr. Chow is the Editor-in-Chief of the Journal of Biopharmaceutical Statistics and the Chapman & Hall/CRC Biostatistics Book Series and the author of 28 books and over 300 methodology papers. He was elected Fellow of the American Statistical Association in 1995.

Author: Gary Walsh
Publisher: John Wiley & Sons
ISBN: 1118687388
Category : Medical
Languages : en
Pages : 544

View

Book Description
The latest edition of this highly acclaimed textbook, provides a comprehensive and up-to-date overview of the science and medical applications of biopharmaceutical products. Biopharmaceuticals refers to pharmaceutical substances derived from biological sources, and increasingly, it is synonymous with 'newer' pharmaceutical substances derived from genetic engineering or hybridoma technology. This superbly written review of the important areas of investigation in the field, covers drug production, plus the biochemical and molecular mechanisms of action together with the biotechnology of major biopharmaceutical types on the market or currently under development. There is also additional material reflecting both the technical advances in the area and detailed information on key topics such as the influence of genomics on drug discovery.

Author: Michael C. Flickinger
Publisher: John Wiley & Sons
ISBN: 1118619277
Category : Science
Languages : en
Pages : 3600

View

Book Description
Biotechnology represents a major area of research focus, and many universities are developing academic programs in the field. This guide to biomanufacturing contains carefully selected articles from Wiley's Encyclopedia of Industrial Biotechnology, Bioprocess, Bioseparation, and Cell Technology as well as new articles (80 in all,) and features the same breadth and quality of coverage and clarity of presentation found in the original. For instructors, advanced students, and those involved in regulatory compliance, this two-volume desk reference offers an accessible and comprehensive resource.

Author: CFA Institute
Publisher: John Wiley & Sons
ISBN: 1119593603
Category : Business & Economics
Languages : en
Pages : 3380

View

Book Description
All CFA® Program exams through November 2021 will reflect the 2020 curriculum. Purchase your copy and begin studying for Level II now! The CFA® Program Curriculum 2020 Level II Box Set provides candidates and other motivated investment professionals with the official curriculum tested on the Level II CFA exam. This set includes practical instruction on the 10 core topics covered in the Candidate Body of Knowledge (CBOK) to prepare readers for their 2020 or 2021 Level II exam windows. Beyond the fundamentals, this set also offers expert guidance on how the CBOK is applied in practice. The Level II CFA® Program Curriculum focuses on complex analysis and asset valuation; it is designed to help candidates use essential investment concepts in real-world situations analysts encounter in the field. Topics explored in this box set include ethical and professional standards, quantitative analysis, economics, financial reporting and analysis, corporate finance, equities, fixed income, derivatives, alternative investments, and portfolio management. Visuals like charts, graphs, figures, and diagrams illustrate complex material covered on the Level II exam, and practice questions with answers help you understand your study progress while reinforcing important content. The CFA® Program Curriculum 2020 Level II Box Set builds from the foundational investment skills covered in Level I. This set helps you: Incorporate analysis skills into case evaluations Master complex calculations and quantitative techniques Understand the international standards used for valuation and analysis Gauge your skills and understanding against each Learning Outcome Statement Perfect for anyone considering the CFA® designation or currently preparing for a 2021 exam window, the 2020 Level II Box Set is a must-have resource for applying the skills required to become a Chartered Financial Analyst®.